Pfizer Inc
NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024
PFE Articles
May 3, 2016: Markets opened lower Tuesday following some overnight weakness in overseas markets resulting from weak data on trade from both China and Europe and a strengthening dollar. Energy prices...
Published:
Last Updated:
Pfizer reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.
Published:
Last Updated:
Pfizer is scheduled to report its first-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and some of the other major companies reporting their quarterly results this week.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Freeport-McMoRan saw a bump in the number of its shares short, while Sprint’s short interest was essentially the same as at the end of March.
Published:
Last Updated:
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical...
Published:
Last Updated:
Apple continues to be the American company with most money parked offshore. The amount has reached $181 billion.
Published:
Last Updated:
These four Jefferies Franchise Picks are rated Buy and pay the highest dividends. They make good sense for investors now.
Published:
Last Updated:
Oxfam reports that 50 U.S. companies have $1.3 trillion offshore. It is hard to figure out why it matters to Oxfam, but the data are true nonetheless.
Published:
Last Updated:
Each week the analysts at Jefferies come out with their top value stock ideas and this week's selections are not only solid ideas, but also pay outstanding dividends.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Some moves in the most heavily shorted stocks traded on the New York Stock Exchange were sizable between the March 15 and March 31 settlement dates.
Published:
Last Updated:
The breakup of the Pfizer-Allergan deal may only be a warning sign for both Apple and Google and any other company filtering money through foreign countries to avoid taxes, but the trend of plugging...
Published:
Last Updated:
Thursday's top analyst upgrades, downgrades and initiations include Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer and Verizon.
Published:
Last Updated: